Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Activating Compound

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 8 of 8
EC Number Activating Compound Commentary Reference
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72cholesterol high levels of DHCR24 are associated with elevated cholesterol concentrations 688975
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72cholestyramine 120fold induction and activation by feeding 5% cholestyramine plus 0.1% lovastatin, CL-diet, and by modulating diurnal variation 288496
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72CO substrate lanosterol: required to inhibit 14alpha-methyl demethylase, 14alpha-demethylation of lanosterol. 14alpha-methyl demethylase activity is dominant over 24-reductase activity, and blockade or removal of 14alpha-methyl demethylase activity is absolutely required for the detection of maximal 24-reductase activity when lanosterol substrate is present. 24-reductase activity is activated in time-dependent manner when 14alpha-methyl demethylase is blocked by CO treatment 288496
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72FAD activate 2fold when added to the assay 654165
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72H2O2 DHCR24 mRNA levels increase in response to oxidative stress (0.1 mM H2O2) in a time-dependent manner, reaching the maximum after 4 h 688975
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72ketoconazole substrate lanosterol: dose-dependent activation, less effective than miconazole, required to inhibit 14alpha-methyl demethylase, 14alpha-demethylation of lanosterol. 14alpha-methyl demethylase activity is dominant over 24-reductase activity, and blockade or removal of 14alpha-methyl demethylase activity is absolutely required for the detection of maximal 24-reductase activity when lanosterol substrate is present 288496
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72lovastatin 120fold induction and activation by feeding 5% cholestyramine plus 0.1% lovastatin, CL-diet, and by modulating diurnal variation 288496
Show all pathways known for 1.3.1.72Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.72miconazole substrate lanosterol: dose-dependent activation, maximum activation with about 0.01 mM miconazole, required to inhibit 14alpha-methyl demethylase, 14alpha-demethylation of lanosterol. 14alpha-methyl demethylase activity is dominant over 24-reductase activity, and blockade or removal of 14alpha-methyl demethylase activity is absolutely required for the detection of maximal 24-reductase activity when lanosterol substrate is present 288496
Results 1 - 8 of 8